We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Haemonetics Corp | NYSE:HAE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.95 | -2.05% | 93.25 | 95.305 | 93.00 | 94.68 | 911,094 | 01:00:00 |
From May 2023 to May 2024
By Will Feuer
Medical-technology company Haemonetics said it has received clearance from the Food and Drug Administration for enhancements to its NexSys PCS plasma-collection system.
The enhancements include a new plasma collection bowl and technology engineered to reduce procedure time, which the company expects to average between 33 minutes and 38 minutes.
The company said it is planning an initial market release of the system with its enhancements in the coming months.
The plasma business is Haemonetics' largest in terms of revenue, posting $131.2 million in the fourth quarter, up about 30% from a year ago.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
June 22, 2023 06:52 ET (10:52 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Haemonetics Chart |
1 Month Haemonetics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
